MyBestHealthPortal.net: Better Health Through Better Knowledge

Switch to desktop Register Login

knee-replacementDuring the past three decades there has been a dramatic, 130-fold increase in knee replacement surgeries, particularly among individuals in their 50s, according to a Finnish study. 

Thursday, 28 November 2013 00:00
Read more...

heart healthReducing Your Risk of Heart Disease

Heart disease is the leading cause of death for both women and men in the United States.

Worldwide, coronary heart disease kills more than 7 million people each year. 

You can reduce your chances of getting heart disease by taking these steps:

Published in Heart Disease
Read more...

woman-drinking-green-teaDrinking Green Tea can Save your Teeth

New research reveal that drinking green tea may be an effective way to help keep teeth and gums healthy and reduce your risk to several diseases caused by the bacteria associated with poor gum health.

A new study, published in the Journal of Periodontology, revealed that a group of men who regularly drank green tea had very healthy teeth and gums, and less periodontal disease compared to those who did not routinely drink green tea. Periodontal (gum) diseases, including gingivitis and periodontitis, are serious infections that, left untreated, can not only lead to tooth loss, but new studies indicate that periodontal is associated with the progression of other diseases such as cardiovascular disease and diabetes.

Published in Dental Conditions
Read more...

Reducing Your Risk of Heart Disease

heart health2Worldwide, coronary heart disease kills more than 7 million people each year. Reduce your chances of getting heart disease with these nine tips: 

Published in Heart Disease
Read more...

alzheimers_drug_failure_3Promisng Alzheimer's Disease Drug Dimebon Fails

A promising Alzheimer's disease drug Dimebon worked no better than a placebo in a late-stage study. An unexpected disappointment after Dimebon, the potential blockbuster, stopped Alzheimer’s symptoms from worsening for a year in a prior test. Dimebon, failed to meet its primary and secondary goals improving thinking ability and overall daily function over six months in patients with mild to moderate Alzheimer's disease.

Published in Alzheimers
Read more...

External links are provided for reference purposes. The World News II is not responsible for the content of external Internet sites. Template Design © Joomla Templates | GavickPro. All rights reserved.

Top Desktop version